Secukinumab treatment of IgA nephropathy manifested by psoriasis complicated with nephrotic syndrome： a case report

Secukinumab treatment of IgA nephropathy manifested by psoriasis complicated with nephrotic syndrome： a case report

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	Xie Ting-ting, Zang Wen-wen, Du Xian-hong, Li Jie, Li Xiu-zhen, Yang Rui-heng, Ma Zhong-chao, Hong Hong
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Nephrology 2025-03-01
Series:	Linchuang shenzangbing zazhi
Subjects:	IgA nephropathy Psoriasis Nephrotic syndrome Secukinumab
Online Access:	http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2025.03.013
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Secukinumab treatment of IgA nephropathy manifested by psoriasis complicated with nephrotic syndrome： a case report
by: Xie Ting-ting, et al.
Published: (2025-03-01)

Successful Treatment with Secukinumab in a Psoriasis Patient on Hemodialysis
by: Xiao Y, et al.
Published: (2025-07-01)

IgA Nephropathy Associated with IgA Vasculitis Coexisting with Focal Segmental Glomerulosclerosis Tip Variant
by: Zitlali Guadalupe Paulín Zepeda, et al.
Published: (2023-07-01)

Clinical features, pathological characteristics, and prognosis of patients with IgA nephropathy complicated with nephrotic syndrome
by: Li Tan, et al.
Published: (2025-01-01)

Effect of Telitacicept on Circulating Gd-IgA1 and IgA-Containing Immune Complexes in IgA Nephropathy
by: Jincan Zan, et al.
Published: (2024-04-01)

Significance of serum IgA/C3 ratio in the diagnosis and prognosis of IgA nephropathy
by: XIE Wei-ji, et al.
Published: (2019-01-01)

IgA Nephropathy in the Elderly
by: Dana V. Rizk, et al.
Published: (2025-08-01)

Serum IgA/C3 ratio as a diagnostic and prognostic biomarker for IgA nephropathy
by: Anitha Swamy, et al.
Published: (2025-08-01)

Application of hydroxychloroquine for IgA nephropathy
by: Xiao Yong-zhen, et al.
Published: (2021-01-01)

Recent advances of precise treatment strategies for IgA nephropathy
by: Liu Xing-hong, et al.
Published: (2022-03-01)

Clinical observation on Shenning mixture in treating IgA nephropathy
by: LIU Hong-yan, et al.
Published: (2016-01-01)

Research advances on the pathogenesis of IgA nephropathy
by: Lu Fang-cao, et al.
Published: (2022-02-01)

Study on the relationship between plasma Gd-IgA1 concentration and disease severity in IgA nephropathy and its production mechanism
by: DAI Qin, et al.
Published: (2020-01-01)

Differential expression of microRNAs in peripheral B lymphocytes in patients with IgA nephropathy and its clinical significance
by: WANG Qian-liao, et al.
Published: (2016-01-01)

Corticosteroid Effects in IgA Nephropathy by Baseline Proteinuria and Estimated GFR
by: Dana Kim, et al.
Published: (2025-06-01)

Correlation between serum homocysteine level and clinicopathological factors of IgA nephropathy
by: Cai Xiao-fan, et al.
Published: (2025-01-01)

Single-Cell RNA-Sequencing Analysis Provides Insights into IgA Nephropathy
by: Ming Xia, et al.
Published: (2025-01-01)

Clinicopathological characteristics and related factors of IgA nephropathy with hyperuricemia
by: Ren Hui-min, et al.
Published: (2021-01-01)

The value of biomarkers in the diagnosis and prognostic analysis of IgA nephropathy
by: Lu Min, et al.
Published: (2025-01-01)

Recent advances on non-immunosuppressive treatment of IgA nephropathy
by: Ding Wan, et al.
Published: (2025-07-01)

The dysbiosis of gut microbiota and dysregulation of metabolites in IgA nephropathy and membranous nephropathy
by: Lei Zhang, et al.
Published: (2025-07-01)

Clinicopathological analysis of IgA nephropathy combined with hyperuricemia
by: CAI Wei-cheng, et al.
Published: (2016-01-01)

Effectiveness and safety of glucocorticoid combined with RAAS inhibitors for treatment of IgA nephropathy
by: ZHOU Ying, et al.
Published: (2020-01-01)

Personal thoughts of IgA nephropathy and purpura nephritis in children
by: Zhang Hong-wen
Published: (2022-07-01)

Characteristics of adult membranous nephropathy patients with capillary co-deposition of IgG and IgA
by: Yi Guan, et al.
Published: (2025-12-01)

Clinicopathological features of IgA nephropathy in children and adults assessed by the Oxford classification and glomerular crescent lesion typing
by: Bai Qiu-yu, et al.
Published: (2025-03-01)

Analysis on effects of different treatment regimens for patients with IgA nephropathy
by: ZHU Ming-zhi, et al.
Published: (2019-01-01)

Clinical features and pathological changes in adult IgA nephropathy with dyslipidemia
by: LIU Rui, et al.
Published: (2019-01-01)

Current status of clinical studies of IgA nephropathy with minimal proteinuria
by: SHI Yu-zhen, et al.
Published: (2020-01-01)

The Prevalence and Characteristics of IgA Antibodies to β2-Spectrin and CBX3 in Immunoglobulin A Nephropathy
by: Ayako Koizumi, et al.
Published: (2025-05-01)

Urinary sediment mRNA as a potent biomarker of IgA nephropathy
by: Jin Sug Kim, et al.
Published: (2024-11-01)

Establishment of modified IgA nephropathy rat model and assessment of oxidative stress
by: GAO Ming, et al.
Published: (2018-01-01)

Study on Cyclosporin A in intervening the progress of IgA nephropathy
by: LU Fa-ju, et al.
Published: (2016-01-01)

Carboxymethyl-lysine is a Prominent Target of Circulating IgA in IgA Nephropathy
by: Sara Alibrandi, et al.
Published: (2025-07-01)

Clinical significance of glomerular IgM deposit in IgA nephropathy: a 5-year follow-up study
by: Ziyuan Huang, et al.
Published: (2024-12-01)

Iron metabolism and chronic inflammation in IgA nephropathy
by: Zhang-yu Tian, et al.
Published: (2023-12-01)

Novel Treatment Paradigms: Primary IgA Nephropathy
by: Haresh Selvaskandan, et al.
Published: (2024-02-01)

Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy
by: Hiddo J.L. Heerspink, et al.
Published: (2025-01-01)

Clinical analysis of 30 cases of patients with nutcracker syndrome complicated with IgA nephropathy
by: WANG Ming-jun, et al.
Published: (2019-01-01)

Secukinumab: In psoriasis and beyond
by: Aditya K. Bubna, et al.
Published: (2025-01-01)